Sutton, who left B-M last year (PRWeek, 3 July 2003), said Axon also envisaged handling corporate comms and public affairs remits in the ‘longer term’.
‘Pharma companies make huge investment in the trials process – many don’t get credit for this,’ said Sutton, who launched Axon’s six-strong UK office last October as managing partner.
He has since hired staff including director Clare Lucker from Avenue HKM.
Axon is a subsidiary of Canada’s National Public Relations and has clients including Merck & Co.
